Kim Hong-Ah, Shin Ju-Young, Kim Mi-Hee, Park Byung-Joo
Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Korea.
Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Korea; Department of Preventive Medicine, College of Medicine, Seoul National University, Seoul, Korea.
PLoS One. 2014 Jun 10;9(6):e98043. doi: 10.1371/journal.pone.0098043. eCollection 2014.
Polypharmacy is widespread in the elderly because of their multiple chronic health problems. The objective of this study was to investigate the prevalence and predictors associated with polypharmacy in a nationally representative sample of Korean elderly individuals.
We used the Korea Health Insurance Review and Assessment Service - National Patient Sample (HIRA-NPS) data from 2010 and 2011. We used information on 319,185 elderly patients (aged 65 years or older) between January 1, 2010 and December 31, 2011 from the HIRA-NPS database. We defined 'polypharmacy' as the concurrent use of 6 medications or more per person, 'major polypharmacy' as 11 medications or more, and 'excessive polypharmacy' as 21 medications or more. The frequency and proportion (%) and their 95% confidence intervals were presented according to the polypharmacy definition. Polypharmacy was visualized by the Quantum Geographic Information Systems (QGIS) program to describe regional differences in patterns of drug use. Multivariate ordinal logistic regression was performed to estimate odds ratios (ORs) and their 95% confidence intervals (CI) to investigate the risk factors for polypharmacy.
Of the Korean elderly studied, 86.4% had polypharmacy, 44.9% had major polypharmacy and 3.0% had excessive polypharmacy. Polypharmacy was found to be primarily concentrated in the Southwest region of the country. Significant associations between polypharmacy and the lower-income Medical Aid population (OR = 1.52, 95% CI 1.47, 1.56) compared with National Health Insurance patients was observed.
Nationwide efforts are needed for managing polypharmacy among Korean elderly patients. In particular, a national campaign and education to promote appropriate use of medicines for the Medical Aid population is needed.
由于患有多种慢性健康问题,多重用药在老年人中很普遍。本研究的目的是调查韩国具有全国代表性的老年人群体中多重用药的患病率及其相关预测因素。
我们使用了2010年和2011年韩国健康保险审查与评估服务中心的全国患者样本(HIRA-NPS)数据。我们从HIRA-NPS数据库中获取了2010年1月1日至2011年12月31日期间319185名老年患者(年龄在65岁及以上)的信息。我们将“多重用药”定义为每人同时使用6种或更多药物,“重度多重用药”定义为11种或更多药物,“过度多重用药”定义为21种或更多药物。根据多重用药的定义呈现频率和比例(%)及其95%置信区间。通过量子地理信息系统(QGIS)程序对多重用药情况进行可视化处理,以描述药物使用模式的区域差异。进行多变量有序逻辑回归以估计优势比(OR)及其95%置信区间(CI),以研究多重用药的危险因素。
在研究的韩国老年人中,86.4%存在多重用药情况,44.9%存在重度多重用药情况,3.0%存在过度多重用药情况。发现多重用药主要集中在该国西南部地区。观察到与国民健康保险患者相比,多重用药与低收入医疗救助人群之间存在显著关联(OR = 1.52,95% CI 1.47,1.56)。
需要在全国范围内努力管理韩国老年患者的多重用药问题。特别是,需要开展全国性运动和教育,以促进医疗救助人群合理用药。